Tu Periódico, 14 de julio

[follow.it]

Noticias SLaai Diferencia entre alergia e intolerancia alimentaria por iva...@gmail.com Jul 13, 2024 Este video explica de una manera muy sencilla la diferencia entre alergia e intolerancia alimentaria, cómo nos afectan, cuáles son los actuales tratamientos y por qué no deberíamos dejar de tomar ciertos alimentos si no somos alérgicos a ellos... Continuar Leyendo Identifican nuevo tratamiento potencial para las alergias alimentarias por iva...@gmail.com Jul 13, 2024 Un estudio de la Universidad de Michigan (EEUU) ha identificado un nuevo tratamiento potencial para las alergias alimentarias en la inulina, una fibra vegetal natural que se utiliza habitualmente como suplemento, prebiótico en refrescos, sustituto de edulcorantes y para otros productos y fines. En lo que parece ser un avance importante que ofrece la promesa de alivio a las personas que sufren alergias alimentarias en todo el mundo, el artículo publicado en Nature Materials describe el éxito de la inmunoterapia oral basada en gel de inulina para detener las reacciones alérgicas... Continuar Leyendo

Allergy, Asthma and Immunology Multiplex LAMP assay for detecting the prevalent species of dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus in the domestic environment por iva...@gmail.com Jul 13, 2024 Shuai, Y., Xue, Q., Tu, H. et al. Sci Rep 14, 16156 (2024). https://doi.org/10.1038/s41598-024-66043-8 Abstract Dermatophagoides farina (D. farinae) and Dermatophagoides pteronyssinus (D. pteronyssinus) are the prevalent kinds of house dust mites (HDMs). HDMs are common inhalant allergens that cause a range of allergic diseases, such as rhinitis, atopic dermatitis, and asthma. The epidemiology of these diseases is associated with exposure to mites. Therefore, in the present study, a method named multiplex loop-mediated isothermal amplification (LAMP) was developed to detect environmental dust mites... Continuar Leyendo Unraveling the Molecular Threads: A Comprehensive Review of the Pathogenesis and Therapeutic Insights Into Allergic Rhinitis. por iva...@gmail.com Jul 13, 2024 Sharma A, Deshmukh P, Jain S, et al. Cureus 16(7): e64410. doi:10.7759/cureus.64410 Abstract Allergic rhinitis (AR) is a prevalent inflammatory disorder of the nasal mucosa, triggered by allergen exposure and characterized by symptoms such as sneezing, nasal congestion, itching, and rhinorrhea. This comprehensive review aims to unravel the molecular mechanisms underpinning AR, exploring the pathogenesis from allergen recognition to chronic inflammation and tissue remodelling. Central to the disease are immunoglobulin E (IgE)-mediated hypersensitivity reactions, involving key inflammatory mediators and cellular players such as mast cells, eosinophils, and T cells... Continuar Leyendo BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: A Delphi consensus study por iva...@gmail.com Jul 13, 2024 Marrs T, Patel N, Burrell S, et al.  Clin Exp Allergy. 2024; 00: 1-11. doi:10.1111/cea.14491 Abstract Background Palforzia® enables the safe and effective desensitisation of children with peanut allergy. The treatment pathway requires multiple visits for dose escalation, up-dosing, monitoring of patients taking maintenance therapy and conversion onto daily real-world peanut consumption. The demand for peanut immunotherapy outstrips current National Health Service (NHS) capacity and requires services to develop a national consensus on how best to offer Palforzia® in a safe and equitable manner. We undertook a Delphi consensus exercise to determine guidance statements for the implementation of Palforzia®-based immunotherapy in the NHS... Continuar Leyendo Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades por iva...@gmail.com Jul 13, 2024 Perret JL, Idrose NS, Walters EH, et al. Allergy. 2024; 00: 1-15. doi:10.1111/all.16184 Abstract Introduction Evidence on the early life risk factors of adult CRS, and the history of asthma and allergies across the life course, is limited. Aim To investigate relationships between respiratory infective/allergic conditions in childhood, and asthma and allergies across the life course and CRS in middle age. Methods Data were from the population-based Tasmanian Longitudinal Health Study (TAHS) cohort, first studied in 1968 when aged 6–7 years (n = 8583) and serially followed into middle age (n = 3609). Using a well-accepted epidemiological definition, participants were assigned a CRS-severity subtype at age 53: no sinusitis/CRS (reference); past doctor diagnosis only; current symptoms without doctor diagnosis; and doctor-diagnosed CRS with current symptoms... Continuar Leyendo